Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

GxP System Validation: PLCs, SCADA and Distributed Control Systems

Posted on November 15, 2025November 14, 2025 By digi


GxP System Validation: PLCs, SCADA and Distributed Control Systems

Comprehensive Guide to GxP System Validation for PLCs, SCADA, and Distributed Control Systems

In the highly regulated pharmaceutical manufacturing environment, GxP system validation is a critical activity, particularly when it concerns programmable logic controllers (PLCs), supervisory control and data acquisition (SCADA) systems, and distributed control systems (DCS). These automated control frameworks are essential for ensuring manufacturing consistency, data integrity, and compliance with regulatory requirements such as those established by the FDA, EMA, and MHRA. This tutorial-style guide provides a step-by-step approach to effective validation of these systems, delving into regulatory expectations, practical implementation strategies, and alignment with international standards like ICH Q7 and PIC/S guidelines.

Understanding GxP System Validation within PLCs, SCADA, and DCS

Before progressing into the validation methodology, it is essential to grasp the foundational concepts behind gxp system validation and the roles of

PLCs, SCADA, and DCS in pharmaceutical manufacturing.

What is GxP System Validation?

GxP system validation refers to the documented process that verifies a computerized system performs as intended in a regulated environment, satisfying predefined specifications. The “GxP” acronym encompasses various good practice regulations such as Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and Good Clinical Practice (GCP), each with specific compliance expectations. In pharmaceutical manufacturing, system validation verifies that equipment and computerized systems consistently produce products meeting quality and safety standards.

The lifecycle of validation spans planning, design qualification, installation qualification, operational qualification, and performance qualification (IQ, OQ, PQ). Validation not only mitigates risks but also ensures that systems maintain data integrity, traceability, and reproducibility – all crucial for compliance during regulatory inspections.

Role of PLCs, SCADA, and DCS in Controlled Manufacturing Environments

  • PLCs are industrial digital computers that control various machine processes, replacing relay logic with programmable software. They are often embedded within equipment lines, executing control logic such as motor sequencing, valve operation, and alarm triggering.
  • SCADA systems provide centralized monitoring and control over multiple PLCs or other devices. SCADA software collects real-time data, tracks process variables, and enables operator intervention via human-machine interfaces (HMIs).
  • Distributed Control Systems (DCS) integrate control functions over a geographically dispersed environment or complex process lines, combining system components including controllers, sensors, actuators, and operator interfaces for full process management.

Each of these system categories qualifies as a gxp computer system due to their direct influence on product quality and data generation. Therefore, a robust validation strategy tailored to the inherent automation and IT architecture is mandatory.

Step 1: Planning the GxP System Validation Strategy

A detailed validation plan forms the backbone of compliant computer system validation and should be developed early, referencing applicable regulations and ensuring it accommodates the complex interactions between PLCs, SCADA, and DCS.

Also Read:  Computer System Validation in Pharmaceutical Industry: Calibration and Maintenance Systems

Define the Scope and Classification

Start by categorizing the system’s intended use, impact on product quality, and patient safety. This includes:

  • Determining which components (PLCs, SCADA, or DCS modules) are within scope.
  • Assessing the risk associated with the system’s failures or malfunctions, aligned with ICH Q9 Quality Risk Management principles.
  • Classifying the system based on GAMP® 5 categories: Category 4 for configurable off-the-shelf software (e.g., SCADA software) or Category 5 for bespoke PLC firmware and embedded systems.

Develop the Validation Master Plan (VMP)

The VMP documents the overall approach, responsibilities, timelines, and quality expectations. Essential elements include:

  • Identification of critical system functions (e.g., batch control, data logging, alarm management).
  • Specification of interfaces between PLCs and SCADA/DCS layers.
  • Validation deliverables such as URS (User Requirements Specification), FRS (Functional Requirements Specification), and risk assessments.
  • Requirements for data integrity compliance under ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available).

Establish a Cross-Functional Validation Team

The complexity and interdisciplinary nature of PLC/SCADA/DCS validation requires collaboration between:

  • Quality Assurance (QA) for oversight and compliance.
  • Engineering and automation teams for technical insights and custom configurations.
  • IT professionals for network and cybersecurity aspects.
  • Operations personnel for practical usability and maintenance considerations.

This team ensures that both technical and regulatory requirements are consistently met.

Step 2: Requirements Specification and Risk Assessment

Create the User Requirements Specification (URS)

The URS captures what the system must do from the end-user’s perspective, focusing on:

  • Process control objectives, including parameters and setpoints.
  • Data acquisition, storage, and reporting requirements — including audit trail needs and electronic signatures.
  • System availability and fail-safe modes.
  • Integration with upstream/downstream equipment and enterprise systems (LIMS, MES, ERP).

Since PLCs and DCS often contain embedded code, documenting precise functional requirements upfront is critical for effective equipment CSV.

Perform a Formal Risk Assessment

Using methodologies such as Failure Mode and Effects Analysis (FMEA) or HACCP principles, evaluate potential failure points:

  • Risk of erroneous control outputs leading to batch deviations.
  • Potential cybersecurity vulnerabilities affecting operational availability.
  • Data loss or manipulation risks impacting regulatory data integrity requirements.

The risk assessment informs the extent of validation efforts (e.g., test coverage, monitoring controls) and assists in prioritizing critical system features.

Following PIC/S guidelines on risk-based quality management can improve validation efficiency by tailoring efforts commensurate with system risk levels.

Step 3: Design Qualification (DQ) – Technical and Functional Review

Design Qualification validates that the proposed system design meets the specified requirements. In the context of PLCs, SCADA, and DCS:

  • Review the hardware architecture: controllers, input/output modules, network topology.
  • Verify firmware and software versions, making sure they are officially released and applicable to GxP use.
  • Confirm interfaces between PLCs and the SCADA/DCS layers allow secure and controlled data flows.
  • Check compliance with cybersecurity standards, including secure access, authentication, and segregation controls.
  • Evaluate system redundancy and failover capabilities to mitigate downtime risks.
Also Read:  GxP Computer Systems: Cybersecurity Controls for Networked Equipment

The DQ phase should culminate in documented evidence that the technical design aligns with the URS, signed off by all stakeholders. This documentation forms a critical foundation for future qualification phases.

Step 4: Installation Qualification (IQ) – Verifying Proper Implementation

Installation Qualification is the process that verifies the system is installed and configured as per design and manufacturer’s specifications in the operational environment.

Key IQ Activities for PLCs, SCADA and DCS

  • Verify physical installation of PLC racks, controllers, power supplies, communication modules, and network components.
  • Confirm the versions of hardware and software components match those approved in the DQ.
  • Document the rack and wiring diagrams with asset tags and serial numbers.
  • Validate the integrity of network cabling and control room environment conditions (EMI considerations, temperature, humidity).
  • Ensure backup configurations and recovery procedures are established and tested.
  • Check calibration status and maintenance records of any instruments integrated via the control systems.

Because many PLCs are embedded systems, IQ must also consider firmware baseline verification. Establishing a secure and controlled baseline reduces risks of unauthorized modifications.

Step 5: Operational Qualification (OQ) – Functional Testing

OQ verifies the system operates correctly within defined limits under controlled conditions. For PLCs, SCADA, and DCS, this step involves comprehensive testing of automated functions, alarms, and data capture.

Typical OQ Tasks Include:

  • Functional testing of control logic: simulate inputs and verify correct outputs such as valve actuation, motor control, and process interlocks.
  • Alarm testing: trigger alarms and verify notification mechanisms, operator response requirements, and recording within audit trails.
  • Data integrity checks: confirm that data logged by SCADA or DCS is attributed correctly, timestamped, and protected from unauthorized edits.
  • User privilege verification: validate role-based access controls and electronic signature workflows enforce separation of duties and gating of critical actions.
  • Interface testing: verify reliable communication from PLCs to SCADA/DCS layers and further to enterprise IT systems; ensure failover conditions do not compromise data integrity.
  • Cybersecurity testing: penetration tests or vulnerability assessments to confirm network hardening.

Compliance with FDA’s 21 CFR Part 11 requirements for electronic records and electronic signatures must be confirmed throughout OQ activities to ensure regulatory alignment.

Creating Test Protocols

Develop comprehensive test scripts linked to URS and risk assessments to cover all critical system functionalities. Include acceptance criteria with pass/fail definitions. Maintain traceability matrices to link tests to requirements for future audits and inspections.

Step 6: Performance Qualification (PQ) – Confirming System Performance in Real Conditions

PQ confirms that the validated system performs as required under actual operating conditions over time and sustained production cycles. This ensures ongoing compliance and confirms reproducibility of process control.

Conducting PQ for Industrial Control Systems

  • Run the validated system during routine production batches, closely monitoring critical process parameters and control outcomes.
  • Document any deviations or alarms and verify corrective actions comply with internal change control.
  • Evaluate the effectiveness of periodic system backups, disaster recovery procedures, and maintenance activities.
  • Assess operator interaction with control interfaces for clarity and compliance with procedure requirements.
  • Verify continuing alignment with electronic record and signature policies.
Also Read:  CSV in Pharma Industry: Weighing, Dispensing and Manufacturing Equipment Systems

Performance Qualification is often supported by statistical process control (SPC) charts, trend analysis, and quality data reports generated via SCADA or DCS historian modules.

Step 7: Change Control and Revalidation

Validated status must be maintained throughout the operational lifecycle. Manufacturers and quality teams must implement a formal change control process for any modifications to PLC programs, SCADA configurations, or DCS hardware/software components.

Key Considerations Include:

  • Risk-based assessment of proposed changes to determine extent of csv validation required.
  • Testing changes in a non-production environment before deployment.
  • Documenting changes thoroughly with impact analysis.
  • Periodic review and requalification where systemic changes affect validated status, e.g., firmware upgrades, network redesigns.
  • Keeping up to date with regulatory guidance to ensure any new compliance requirements are incorporated promptly.

Maintaining a robust audit trail and configuration management system is indispensable for regulatory inspections and supports ongoing continuous improvement.

Best Practices and Regulatory Compliance Considerations

Effective equipment CSV for these complex automated systems requires strict adherence to regulatory expectations:

  • Data Integrity: All activities must be undertaken with a focus on compliance with the ALCOA+ principles. Systems must have secure audit trails, validated access controls, and preserved original records.
  • Electronic Records and Signatures: Align with EU Annex 11 and FDA 21 CFR Part 11 criteria, ensuring electronic records and signatures are trustworthy, reliable, and equivalent to paper.
  • Traceability: Maintain a clear traceability matrix from URS to test cases and final validation results to facilitate audits and enable rapid issue resolution.
  • Supplier Qualification: For off-the-shelf SCADA software or proprietary PLC firmware, perform supplier audits and review vendor documentation to confirm compliance with GMP expectations.
  • Documentation and Training: Document every phase and train personnel on validated system use, maintenance, and change control processes.

Regulatory authorities such as the MHRA provide clear annexes on computerized system validation which are invaluable references for ensuring compliance during system lifecycle management.

Summary and Final Recommendations

Validating PLCs, SCADA, and distributed control systems under gxp system validation guidelines is essential to guarantee consistent product quality, regulatory compliance, and operational reliability within pharmaceutical manufacturing. The validation process must be structured, risk-based, and meticulously documented throughout all phases: planning, specification, qualification, and ongoing maintenance.

  • Start early with a detailed validation master plan and risk assessment.
  • Create clear and complete specifications aligning technical design with user needs.
  • Thoroughly test in all qualification phases to verify hardware, firmware, software, and interfaces function correctly.
  • Implement sustainable change control and monitoring programs post-qualification.
  • Ensure personnel are trained and quality oversight maintained for data integrity assurance.

Pharmaceutical companies operating under FDA, EMA, and MHRA jurisdictions benefit from adherence to globally harmonized standards such as ICH and PIC/S guidelines, which promote consistent and defensible GMP compliant computer system validation practices. This ensures the integrity and reliability of automated manufacturing processes essential for safeguarding public health.

CSV for Regulated Equipment & Embedded Systems Tags:PLC;SCADA;DCS;automation;equipment control;CSV

Post navigation

Previous Post: GxP Computer Systems: Integrating Equipment Qualification and CSV Activities
Next Post: GxP Computer System Validation: CSV for Laboratory Instruments and Data Systems

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme